Researchers ID receptor tied to neurodegenerative disease

08/26/2013 | Yahoo

A study in the journal Proceedings of the National Academy of Sciences suggests that obstructing the heparan sulfate proteoglycan receptor may offer hope for treating Alzheimer's, Parkinson's and other neurodegenerative disorders. Researchers genetically disabled HSPGs in mice and cell cultures, finding that clumps of tau protein were not able to penetrate cells, which prevented cell-to-cell spread of misfolded tau. The study also linked the receptors to the spread of alpha-synuclein protein, which is involved with Parkinson's disease.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC